Clovis Oncology (NASDAQ: CLVS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Clovis Oncology (NASDAQ: CLVS) through any online brokerage.
The latest price target for Clovis Oncology (NASDAQ: CLVS) was reported by HC Wainwright & Co. on Friday, May 6, 2022. The analyst firm set a price target for 0.00 expecting CLVS to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Clovis Oncology (NASDAQ: CLVS) is $2.85 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Clovis Oncology.
Clovis Oncology’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Clovis Oncology.
Clovis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.